Abstract:Ethnopharmacological relevance: Lean nonalcoholic steatohepatitis (NASH) poses a serious threat to public health worldwide. Herbs of the genus Gentiana have been used for centuries to treat hepatic disease or have been consumed for hepatic protection efficiency. Gentiopicroside (GPS), the main bioactive component of Gentiana herbs, has been shown to be beneficial for protecting the liver, improving intestinal disorders, modulating bile acid profiles, ameliorating alcoholic hepatosteatosis, and so on. It is plausible to speculate that GPS may hold potential as a therapeutic strategy for lean NASH. However, no related studies have been conducted thus far. Aim of the study: The present work aimed to investigate the benefit of GPS on NASH in a lean mouse model. Materials and methods: NASH in a lean mouse model was successfully established via a published method. GPS of 50 and 100 mg/kg were orally administered to verify the effect. Untargeted metabolomics, 16S rDNA sequencing and bile acid (BA) profiling, as well as qPCR and Western blotting analysis were employed to investigate the mechanism underlying the alleviating effect. Results: GPS significantly reduced the increase in serum biochemicals and liver index, and attenuated the accumulation of fat in the livers of lean mice with NASH. Forty-two potential biomarkers were identified by metabolomics analysis, leading to abnormal metabolic pathways of primary bile acid biosynthesis and fatty acid biosynthesis, which were subsequently rebalanced by GPS. A decreased Firmicutes/Bacteroidetes (F/B) ratio and disturbed BA related GM profiles were revealed in lean mice with NASH but were partially recovered by GPS. Furthermore, serum profiling of 23 BAs confirmed that serum BA levels were elevated in the lean model but downregulated by GPS treatment. Pearson correlation analysis validated associations between BA profiles, serum biochemical indices and related GM. qPCR and Western blotting analysis further elucidated the regulation of genes associated with liver lipid synthesis and bile acid metabolism. Conclusions: GPS may ameliorate steatosis in lean mice with NASH, regulating the metabolomic profile, BA metabolism, fatty acid biosynthesis, and BA-related GM. All these factors may contribute to its beneficial effect.

LKB1/AMPK-Mediated Regulation by Gentiopicroside Ameliorates P2x7R-Dependent Alcoholic Hepatosteatosis

Liver Kinase B1/AMP‐activated Protein Kinase‐mediated Regulation by Gentiopicroside Ameliorates P2X7 Receptor‐dependent Alcoholic Hepatosteatosis

Gentiopicroside Ameliorates the Progression from Hepatic Steatosis to Fibrosis Induced by Chronic Alcohol Intake

Ethanol-induced Hepatic Steatosis is Modulated by Glycogen Level in the Liver

Peroxisome Proliferator-Activated Receptor Γ Coactivator 1α Maintains NAD+ Bioavailability Protecting Against Steatohepatitis

Gentiopicroside ameliorates ethanol-induced gastritis via regulating MMP-10 and pERK1/2 signaling

PGC1 protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response

PGC1α protects against hepatic steatosis and insulin resistance via enhancing IL10-mediated anti-inflammatory response.

Integrated serum metabolomics, 16S rRNA sequencing and bile acid profiling to reveal the potential mechanism of gentiopicroside against nonalcoholic steatohepatitis in lean mice

Lycium Barbarum Polysaccharide Supplementation Improves Alcoholic Liver Injury in Female Mice by Inhibiting Stearoyl‐CoA Desaturase 1

Amelioration of Alcoholic Liver Steatosis by Dihydroquercetin Through the Modulation of AMPK-Dependent Lipogenesis Mediated by P2X7R-NLRP3-Inflammasome Activation

Gentiopicroside improves non-alcoholic steatohepatitis by activating PPARα and suppressing HIF1

Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways

Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation Through Nuclear Factor Erythroid 2-Related Factor 2 Activation

P2X7 Receptor‐targeted Regulation by Tetrahydroxystilbene Glucoside in Alcoholic Hepatosteatosis: A New Strategy Towards Macrophage–hepatocyte Crosstalk

Pleurotus Citrinopileatus Alleviates Alcohol-Induced Fatty Liver Via Upregulating AMPK Signaling

Inhibition of P2X7R-NLRP3 Inflammasome Activation by Pleurotus Citrinopileatus: A Possible Protective Role in Alcoholic Hepatosteatosis

Modulation of Interleukin-36 Based Inflammatory Feedback Loop Through the Hepatocyte-Derived IL-36R-P2X7R Axis Improves Steatosis in Alcoholic Steatohepatitis

Lactiplantibacillus plantarum P101 Alleviated Alcohol-Induced Hepatic Lipid Accumulation in Mice via AMPK Signaling Pathway: Gut Microbiota and Metabolomics Analysis

Periplaneta Americana Extract Alleviates Steatohepatitis in a Mouse Model by Modulating HMGB1-mediated Inflammatory Response

Targeting RXFP1 by Ligustilide: A novel therapeutic approach for alcoholic hepatic steatosis